文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

产前维生素D缺乏筛查与治疗项目的有效性:分层随机现场试验

Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

在伊朗两城市开展分层随机现场试验,筛查点800名孕妇中,中重度缺乏者随机接受四种维生素D3方案至分娩。补充后筛查点53%孕妇25(OH)D达充足水平,而非筛查点仅2%;筛查点子痫前期、妊娠期糖尿病和早产分别降低60%、50%和40%。每月50000 IU维持治疗基础上加用D3注射最有助于分娩时达到充足水平。

要点

  • 产前维生素D筛查治疗可提高25(OH)D充足率(筛查点53% vs 非筛查点2%)
  • 筛查点子痫前期、妊娠期糖尿病和早产分别降低60%、50%和40%
  • 每月50000 IU维持治疗加用D3注射最有助于分娩时达到充足水平

核心结论

  • 产前维生素D筛查与治疗项目能有效识别缺乏孕妇、改善25(OH)D水平并减少不良妊娠结局。

研究设计与样本

  • 在伊朗胡齐斯坦省Masjed-Soleyman和Shushtar两城市分别设筛查点与非筛查点,筛查点内对800名18至40岁孕妇开展随机对照试验。

主要发现

  • 补充后非筛查点仅2%孕妇达到25(OH)D充足水平(>20 ng/mL),筛查点为53%。
  • 筛查点子痫前期、妊娠期糖尿病和早产分别降低60%、50%和40%。
  • 在每月50000 IU维持治疗基础上加用D3注射对分娩时达到充足水平贡献最大。

关键数值与推荐

  • 中度缺乏定义为25(OH)D 10至20 ng/mL,重度缺乏定义为25(OH)D <10 ng/mL。
  • 中度和重度缺乏孕妇随机分为四个亚组,接受维生素D3至分娩。
  • 充足水平定义为25(OH)D >20 ng/mL。

临床怎么用

  • 产前维生素D筛查与治疗项目可作为识别缺乏孕妇、改善25(OH)D水平并减少不良妊娠结局的有效方法。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Despite evidence on the association between hypovitaminosis D and adverse pregnancy outcomes and the positive impact of vitamin D supplementation, no evidence exists supporting a universal screening program in pregnancy as part of routine prenatal care. OBJECTIVE: We sought to determine the effectiveness of a prenatal screening program on optimizing 25-hydroxyvitamin D [25(OH)D] levels and preventing pregnancy complications. Also, to identify a safe regimen, we compared several regimens in a subgroup of vitamin D-deficient pregnant women. DESIGN: Two cities of Masjed-Soleyman and Shushtar from Khuzestan province, Iran, were selected as the screening and nonscreening arms, respectively. Within the screening arm, a randomized controlled trial was conducted on 800 pregnant women. SETTING: Health centers of Masjed-Soleyman and Shushtar cities. PATIENTS OR PARTICIPANTS: Pregnant women aged 18 to 40 years. INTERVENTION: Women with moderate [25(OH)D, 10 to 20 ng/mL] and severe [25(OH)D, <10 ng/mL] deficiency were randomly divided into four subgroups and received vitamin D3 (D3) until delivery. MAIN OUTCOME MEASURE: Maternal concentration of 25(OH)D at delivery and rate of pregnancy complications. RESULTS: After supplementation, only 2% of the women in the nonscreening site met the sufficiency level (>20 ng/mL) vs 53% of the women in the screening site. Adverse pregnancy outcomes, including preeclampsia, gestational diabetes mellitus, and preterm delivery, were decreased by 60%, 50%, and 40%, respectively, in the screening site. A D3 injection in addition to monthly 50,000 IU maintenance therapy contributed the most to achievement of sufficient levels at delivery. CONCLUSIONS: A prenatal vitamin D screening and treatment program is an effective approach in detecting deficient women, improving 25(OH)D levels, and decreasing pregnancy adverse outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rostami M, Tehrani FR, Simbar M, et al. Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial. J Clin Endocrinol Metab. 2018. PMID: 29788364. doi:10.1210/jc.2018-00109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。